Novo Nordisk's liraglutide has been approved for children who are at least 12 years old. However, the drug is now being tested on children as young as six years old.
There is a divide among some physicians about if and when children should use weight-loss drugs, which have surged in popularity among adults. In a recent study published in the New England Journal of Medicine, researchers found that Novo Nordisk's drug liraglutide, sold under the brand names Saxenda and Victoza, led to a reduction in body mass index in children between 6 and 12 years old who have obesity.
No medications are currently approved for the treatment of nonmonogenic, nonsyndromic obesity in children younger than 12 years of age," the study said. "Though the use of liraglutide has been shown to induce weight loss in adults and adolescents with obesity, its safety and efficacy have not been established in children.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug marketEli Lilly may be starting to gain an edge over Novo Nordisk in the GLP-1 market. Meanwhile, Stryker will acquire artificial intelligence startup Care.ai.
Read more »